Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1344 ARTÍCULOS , VIENDO DEL 646 AL 660

Diabetes mellitus as a modulator of functional impairment and decline in Alzheimer's disease. The Real.FR cohort

Sanz CM, Hanaire H, Vellas BJ, Sinclair AJ, Andrieu S; REAL.FR Study Group.

Diabet Med. 2012 Apr;29(4):541-8. doi: 10.1111/j.1464-5491.2011.03445.x.

Using mental imagery to improve memory in patients with Alzheimer disease: trouble generating or remembering the mind's eye?

Hussey EP, Smolinsky JG, Piryatinsky I, Budson AE, Ally BA.

Alzheimer Dis Assoc Disord. 2012 Apr-Jun;26(2):124-34. doi: 10.1097/WAD.0b013e31822e0f73.

Crossed aphasia in a dextral patient with logopenic/phonological variant of primary progressive aphasia

Demirtas-Tatlidede A, Gurvit H, Oktem-Tanor O, Emre M.

Alzheimer Dis Assoc Disord. 2012 Jul-Sep;26(3):282-4. doi: 10.1097/WAD.0b013e31823346c6.

Metabolic syndrome, cognitive performance, and dementia

Crichton GE, Elias MF, Buckley JD, Murphy KJ, Bryan J, Frisardi V.

J Alzheimers Dis. 2012;30 Suppl 2:S77-87. doi: 10.3233/JAD-2011-111022.

Bridging the pathophysiology of Alzheimer's disease with vascular pathology: the feed-back, the feed-forward, and oxidative stress

Polidori MC, Pientka L.

J Alzheimers Dis. 2012;28(1):1-9. doi: 10.3233/JAD-2011-111034.

Depressive symptoms in oldest-old women: risk of mild cognitive impairment and dementia

Spira AP, Rebok GW, Stone KL, Kramer JH, Yaffe K.

Am J Geriatr Psychiatry. 2012 Dec;20(12):1006-15. doi: 10.1097/JGP.0b013e318235b611.

Neuropsychological features of mild cognitive impairment and preclinical Alzheimer's disease

Salmon DP.

Curr Top Behav Neurosci. 2012;10:187-212. doi: 10.1007/7854_2011_171.

Does physical activity reduce risk for Alzheimer's disease through interaction with the stress neuroendocrine system?

Tortosa-Martínez J, Clow A.

Stress. 2012 May;15(3):243-61. doi: 10.3109/10253890.2011.629323. Epub 2012 Jan 4.

Variants in CYP17 and CYP19 cytochrome P450 genes are associated with onset of Alzheimer's disease in women with down syndrome

Chace C, Pang D, Weng C, Temkin A, Lax S, Silverman W, Zigman W, Ferin M, Lee JH, Tycko B, Schupf N.

J Alzheimers Dis. 2012;28(3):601-12. doi: 10.3233/JAD-2011-110860.

Obesity, cognitive functioning and dementia: back to the future

Elias MF, Goodell AL, Waldstein SR.

J Alzheimers Dis. 2012;30 Suppl 2:S113-25. doi: 10.3233/JAD-2011-111175.

The progranulin (GRN) Cys157LysfsX97 mutation is associated with nonfluent variant of primary progressive aphasia clinical phenotype

Caso F, Villa C, Fenoglio C, Santangelo R, Agosta F, Coppi E, Falautano M, Comi G, Filippi M, Scarpini E, Magnani G, Galimberti D.

J Alzheimers Dis. 2012;28(4):759-63. doi: 10.3233/JAD-2011-111544.

Neurocognitive dysfunction in the highly active antiretroviral therapy era

Mothobi NZ, Brew BJ.

Curr Opin Infect Dis. 2012 Feb;25(1):4-9. doi: 10.1097/QCO.0b013e32834ef586.

Effects of atorvastatin on cerebral blood flow in middle-aged adults at risk for Alzheimer's disease: a pilot study

Carlsson CM, Xu G, Wen Z, Barnet JH, Blazel HM, Chappell RJ, Stein JH, Asthana S, Sager MA, Alsop DC, Rowley HA, Fain SB, Johnson SC.

Curr Alzheimer Res. 2012 Oct;9(8):990-7. doi: 10.2174/156720512803251075.

Dementia, stroke, and vascular risk factors; a review

Sahathevan R, Brodtmann A, Donnan GA.

Int J Stroke. 2012 Jan;7(1):61-73. doi: 10.1111/j.1747-4949.2011.00731.x.

Factors associated with dementia among elderly people living in two cities in Central Africa: the EDAC multicenter study

Guerchet M, Mouanga AM, M'belesso P, Tabo A, Bandzouzi B, Paraïso MN, Houinato DS, Cowppli-Bony P, Nubukpo P, Aboyans V, Clément JP, Dartigues JF, Preux PM.

J Alzheimers Dis. 2012;29(1):15-24. doi: 10.3233/JAD-2011-111364.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias